Organon (OGN) Total Debt (2020 - 2026)
Organon (OGN) posted Total Debt of $8.6 billion for Q2 2026, little changed on a QoQ basis from $8.6 billion in Q1 2026, and down 4.26% year-over-year from $9.0 billion in Q2 2025.
Analysis
Organon (OGN) Total Debt (2020 - 2026) Analysis & Trends
Organon has reported Total Debt for 7 years, with the latest figure at $8.6 billion in Q2 2026.
- On a quarterly basis, Total Debt fell 4.26% year-over-year to $8.6 billion in Q2 2026; TTM through Jun 2026 was $8.6 billion, a 4.26% decrease from a year earlier, with the FY2025 full-year figure at $8.7 billion, down 2.84% from the prior year.
- Total Debt was $8.6 billion for Q2 2026 at Organon, roughly flat from $8.6 billion in the prior quarter.
- The five-year high for Total Debt was $9.1 billion in Q1 2022, with the low at $8.6 billion in Q1 2026.
- Average Total Debt over 5 years is $8.8 billion, with a median of $8.7 billion recorded in 2023.
- The largest YoY upside for Total Debt was 499.28% in 2022 against a maximum downside of 6.77% in 2022.
- Over 5 years, Total Debt stood at $8.9 billion in 2022, then slipped by 1.63% to $8.8 billion in 2023, then advanced by 1.56% to $8.9 billion in 2024, then fell by 2.84% to $8.7 billion in 2025, then retreated by 0.38% to $8.6 billion in 2026.
- The last three Total Debt figures came in at $8.6 billion (Q2 2026), $8.6 billion (Q1 2026), and $8.7 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 60.73 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 70.82 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 53.91 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 9.59 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 63.19 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 25.19 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 38.81 Mn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | - |
| 10 | Organon | 3.58 Bn | 2.45 Bn | 847.00 Mn | 8.63 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.63 Bn |
| Mar 31, 2026 | 8.59 Bn |
| Dec 31, 2025 | 8.66 Bn |
| Sep 30, 2025 | 8.87 Bn |
| Jun 30, 2025 | 9.01 Bn |
| Mar 31, 2025 | 8.98 Bn |
| Dec 31, 2024 | 8.91 Bn |
| Sep 30, 2024 | 8.76 Bn |
| Jun 30, 2024 | 8.67 Bn |
| Mar 31, 2024 | 8.72 Bn |
| Dec 31, 2023 | 8.78 Bn |
| Sep 30, 2023 | 8.66 Bn |
| Jun 30, 2023 | 8.74 Bn |
| Mar 31, 2023 | 8.72 Bn |
| Dec 31, 2022 | 8.92 Bn |
| Sep 30, 2022 | 8.71 Bn |
| Jun 30, 2022 | 8.91 Bn |
| Mar 31, 2022 | 9.11 Bn |
| Dec 31, 2021 | 9.14 Bn |
| Sep 30, 2021 | 9.34 Bn |